Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
by The Investment U Research Team
We’ve quite a little pool in the office going over who the undisclosed buyer is for General Motors (NYSE: GM) Hummer brand. GM announced yesterday that it had a laundry list of buyers who were lining up for Saturn – they’re also looking to unload the Saab and Pontiac brands.
The joke around here is that it’ll have to be a buyer from an oil rich nation considering the gas mileage of a Hummer. But it will most likely be a foreign buyer, with private funds. Like Dubai World or from the Asian rim nations. Another possibility is a buyer from India.
But its purchase makes sense on other levels of course. Hummer is very popular overseas, and like many popular iconic brands, its popularity will live on past GM’s woes.
While Hummer’s popularity is debated – many see these large SUVs as the antithesis of the green movement because of their inefficiency and gas guzzling needs – the fact of the matter is this brand keeps producing vehicles that a small group of devoted buyers like.
Unfortunately, we don’t see an angle for investors that will allow them to profit from this. Our only thought lies in bottom feeding on the bankrupt stock price of GM. It will hit a bottom like American International Group (NYSE: AIG), Citigroup (NYSE: C) and a number of other crash casualties, which have all risen since their bottoms.
Symbols mentioned in this article: GM, AIG and C.
- China Goes Green, Dumps Hummer
- Plug-In Electric Vehicles: In Search of the Mass-Produced Hybrid
- Bond Market’s Glimpse Into 2009
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed